OncologyEducation (@onced) 's Twitter Profile
OncologyEducation

@onced

Evidence-based, educational resources for the oncology community. Authored exclusively by a leading international faculty of oncology.

ID: 84617554

linkhttp://www.oncologyeducation.com calendar_today23-10-2009 15:30:22

29,29K Tweet

6,6K Followers

2,2K Following

OncologyEducation (@onced) 's Twitter Profile Photo

This Wednesday! Join us in Montreal for a full recap of high-impact data and breakthroughs from this year's ASCO. 🌎 Global evidence, local impact. 🗓️ One day. All the highlights. 🇨🇦 Led by Canadian experts for Canadian practice. ow.ly/Pacq50W9hP8

This Wednesday! Join us in Montreal for a full recap of high-impact data and breakthroughs from this year's ASCO. 

🌎 Global evidence, local impact.
🗓️ One day. All the highlights.
🇨🇦 Led by Canadian experts for Canadian practice.

ow.ly/Pacq50W9hP8
OncologyEducation (@onced) 's Twitter Profile Photo

Quebec healthcare professionals! Join us tomorrow at Best of ASCO Montreal for a concise recap of the top trials and takeaways from this year's congress. 🌎 Global evidence, local impact. 🗓️ One day. All the highlights. 🇨🇦 Led by Canadian experts ow.ly/PzR350W9hPa

Quebec healthcare professionals! Join us tomorrow at Best of ASCO Montreal for a concise recap of the top trials and takeaways from this year's congress. 

🌎 Global evidence, local impact.
🗓️ One day. All the highlights.
🇨🇦 Led by Canadian experts 

ow.ly/PzR350W9hPa
OncologyEducation (@onced) 's Twitter Profile Photo

Missed this year's ASCO? Join us VIRTUALLY this Friday for a recap of top trials and breakthroughs. Best of ASCO Vancouver Conference will provide the insights that matter, with practical guidance you can implement immediately. 🎟️ ow.ly/f66C50WbXgn #ASCO25 Sharlene Gill, MD, MPH, MBA, FASCO

Missed this year's ASCO? Join us VIRTUALLY this Friday for a recap of top trials and breakthroughs. 
Best of ASCO Vancouver Conference will provide the insights that matter, with practical guidance you can implement immediately. 

🎟️ ow.ly/f66C50WbXgn

#ASCO25 <a href="/GillSharlene/">Sharlene Gill, MD, MPH, MBA, FASCO</a>
OncologyEducation (@onced) 's Twitter Profile Photo

Melanoma care is moving fast. Get key takeaways from the Canadian Melanoma Conference: 🧬 Immunotherapy 🧪 Biomarkers 🩺 Rare tumours 🔍 Surgical/systemic updates 🎥 Watch now → ow.ly/jQR850W82sR #Melanoma #CMC2025 #CancerCare

Melanoma care is moving fast.

Get key takeaways from the Canadian Melanoma Conference:
🧬 Immunotherapy
🧪 Biomarkers
🩺 Rare tumours
🔍 Surgical/systemic updates

🎥 Watch now  → ow.ly/jQR850W82sR

#Melanoma #CMC2025 #CancerCare
OncologyEducation (@onced) 's Twitter Profile Photo

📍 We’re live in Vancouver today for the final stop of our Best of ASCO Conference! Follow along as we showcase incredible presentations from leading experts in oncology. ✨ Haven’t registered yet? Join us virtually and be part of the experience: ow.ly/ljIK50We2VF

OncologyEducation (@onced) 's Twitter Profile Photo

🎤 Kicking things off in Vancouver with Dr. Alina Gerrie BC Cancer who’s taking us through the latest insights and advancements in Lymphoma. We’re just getting started at Best of ASCO Vancouver — stay tuned for more expert-led sessions! #BOAV25 #ASCO25 #OncEd #lymphoma

🎤 Kicking things off in Vancouver with Dr. Alina Gerrie <a href="/BCCancer/">BC Cancer</a>  who’s taking us through the latest insights and advancements in Lymphoma.

We’re just getting started at Best of ASCO Vancouver — stay tuned for more expert-led sessions! #BOAV25 #ASCO25 #OncEd #lymphoma
OncologyEducation (@onced) 's Twitter Profile Photo

📣 Next up at Best of ASCO Vancouver: Dr. Cheryl Ho BC Cancer is diving into the latest research and treatment updates in Lung Cancer. Her session highlights key takeaways from ASCO and what they mean for patient care in Canada and beyond. #BOAT25 #ASCO25 #OncEd #LungCancer

📣 Next up at Best of ASCO Vancouver: Dr. Cheryl Ho <a href="/BCCancer/">BC Cancer</a>  is diving into the latest research and treatment updates in Lung Cancer.

Her session highlights key takeaways from ASCO and what they mean for patient care in Canada and beyond. #BOAT25 #ASCO25 #OncEd #LungCancer
OncologyEducation (@onced) 's Twitter Profile Photo

📢 On stage now: Dr. Jonathon Loree BC Cancer presenting on Colorectal and GI Cancers. He’s breaking down key data from ASCO and what it means for evolving treatment strategies in gastrointestinal oncology. More expert insights coming your way from Vancouver! #BOAV25 #ASCO25

📢 On stage now: Dr. Jonathon Loree <a href="/BCCancer/">BC Cancer</a>  presenting on Colorectal and GI Cancers.

He’s breaking down key data from ASCO and what it means for evolving treatment strategies in gastrointestinal oncology.

More expert insights coming your way from Vancouver! #BOAV25 #ASCO25
OncologyEducation (@onced) 's Twitter Profile Photo

🔬Led by Sharlene Gill, MD, MPH, MBA, FASCO our Canadian Research Spotlight shines on a groundbreaking study from the #CCTG. We’re diving into the CHALLENGE Trial. Exciting to see Canadian-led research shaping the future of cancer care. 🇨🇦 #BOAV25 #ASCO25 #CHALLENGETrial #ColonCancer

🔬Led by <a href="/GillSharlene/">Sharlene Gill, MD, MPH, MBA, FASCO</a>  our Canadian Research Spotlight shines on a groundbreaking study from the #CCTG.

We’re diving into the CHALLENGE Trial. Exciting to see Canadian-led research shaping the future of cancer care. 🇨🇦

#BOAV25 #ASCO25 #CHALLENGETrial #ColonCancer
OncologyEducation (@onced) 's Twitter Profile Photo

☀️ Next up: Dr. John Walker is taking the stage to present the latest Melanoma updates from ASCO. From immunotherapy advances to new clinical trial data, this session highlights what’s shaping the future of melanoma treatment and patient outcomes. #Melanoma #ASCO25 #BOAV25

OncologyEducation (@onced) 's Twitter Profile Photo

Dr. Aalok Kumar shares the latest Breast Cancer updates from ASCO. From novel therapies to evolving standards of care, this session offers key insights into the current landscape & future direction of breast cancer treatment. Stay tuned for more from #BOAV25 #ASCO25 #OncEd

Dr. Aalok Kumar shares the latest Breast Cancer updates from ASCO.

From novel therapies to evolving standards of care, this session offers key insights into the current landscape &amp; future direction of breast cancer treatment.

Stay tuned for more from #BOAV25

#ASCO25 #OncEd
OncologyEducation (@onced) 's Twitter Profile Photo

Couldn’t make it to ASCO®? Access the key findings, interpreted by Canadian experts, in short, digestible sessions from our Best of ASCO® Toronto Conference. 💡 Learn what matters, when it works for you. All sessions available here: ow.ly/B9W850Wecyg #BOAT25 #OncEd #MedOnc

Couldn’t make it to ASCO®?
Access the key findings, interpreted by Canadian experts, in short, digestible sessions from our Best of ASCO® Toronto Conference.
💡 Learn what matters, when it works for you. All sessions available here: ow.ly/B9W850Wecyg

#BOAT25 #OncEd #MedOnc
OncologyEducation (@onced) 's Twitter Profile Photo

🍽️ Daniel Heng presents the Ipsen Lunch Symposium: "Shifting Paradigms in RCC: Optimizing Sequencing, Risk Stratification, and Clinical Practices with Long-Term Data and Emerging Therapies." Proud to spotlight this critical discussion at #BOAV25 #ASCO2025 #RCC

🍽️ <a href="/DrDanielHeng/">Daniel Heng</a>  presents the Ipsen Lunch Symposium: "Shifting Paradigms in RCC: Optimizing Sequencing, Risk Stratification, and Clinical Practices with Long-Term Data and Emerging Therapies."

Proud to spotlight this critical discussion at #BOAV25

#ASCO2025 #RCC
OncologyEducation (@onced) 's Twitter Profile Photo

🔍 Dr. Maryam Soleimani shares the latest updates in non-prostate genitourinary cancers. From bladder to kidney cancers, she’s covering key findings and emerging therapies that are reshaping care beyond prostate cancer. More insights ahead at #BOAV25 #ASCO25 #OncEd

🔍 Dr. Maryam Soleimani shares the latest updates in non-prostate genitourinary cancers.

From bladder to kidney cancers, she’s covering key findings and emerging therapies that are reshaping care beyond prostate cancer.

More insights ahead at #BOAV25

#ASCO25 #OncEd
OncologyEducation (@onced) 's Twitter Profile Photo

🧬 Steve Yip, MD, MSc presents the latest Prostate Cancer updates from #ASCO25. This session highlights new data, evolving treatment strategies, and the impact of precision medicine in improving outcomes for patients with prostate cancer. #ProstateCancer #BOAV25

🧬 <a href="/Yipilimumab/">Steve Yip, MD, MSc</a> presents the latest Prostate Cancer updates from #ASCO25.

This session highlights new data, evolving treatment strategies, and the impact of precision medicine in improving outcomes for patients with prostate cancer.

#ProstateCancer #BOAV25
OncologyEducation (@onced) 's Twitter Profile Photo

Dr. Howard Lim BC Cancer takes the stage to discuss the latest in non-colorectal GI cancer updates from #ASCO25. Covering breakthroughs in cancers of the pancreas, stomach, esophagus, and more -this session dives into key clinical findings and what they mean for patient care.

Dr. Howard Lim <a href="/BCCancer/">BC Cancer</a> takes the stage to discuss the latest in non-colorectal GI cancer updates from #ASCO25.

Covering breakthroughs in cancers of the pancreas, stomach, esophagus, and more -this session dives into key clinical findings and what they mean for patient care.
OncologyEducation (@onced) 's Twitter Profile Photo

🎤Dr. Nicole Chau presents the latest Head & Neck Cancer updates from #ASCO25. This session explores emerging treatments, clinical trial highlights, and evolving standards of care in this diverse and challenging group of cancers. #HeadAndNeckCancer #BOAV25

🎤Dr. Nicole Chau presents the latest Head &amp; Neck Cancer updates from #ASCO25.

This session explores emerging treatments, clinical trial highlights, and evolving standards of care in this diverse and challenging group of cancers.
 
#HeadAndNeckCancer #BOAV25
OncologyEducation (@onced) 's Twitter Profile Photo

🎉 That’s a wrap! We’ve officially concluded #BOAV25 marking the end of an incredible cross-country series. A huge thank you to all our Chairs Sharlene Gill, MD, MPH, MBA, FASCO and Dr. Anil Joy, our speakers, attendees, and partners who made this event such a success #ASCO25 #OncEd #CancerCare

OncologyEducation (@onced) 's Twitter Profile Photo

Less travel. Less time in clinic. Oral decitabine–cedazuridine may offer a practical alternative for MDS and CMML patients needing flexible treatment options. 👀 Check out the data in our latest infographic: ow.ly/84RM50WcvWn #MDS #CMML #Infographic #OncEd #MedOnc